Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Expression of the nm23-H1 gene and loss of heterozygosity in malignant melanoma (CROSBI ID 496300)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Anđelinović, Deny ; Pavelić, Krešimir ; Kapitanović, Sanja ; Anđelinović, Šimun ; Tomić, Snježana ; Marasović, Dujomir ; Erceg Ivkošić, Ivana ; Kuret, Sendi ; Franulović, Vesna ; Primorac, Dragan Expression of the nm23-H1 gene and loss of heterozygosity in malignant melanoma // 3rd European-American School in Forensic Genetics and Mayo Clinic Course in Advanced Molecular and Cellular Medicine, abstract book / Primorac, Dragan (ur.). Zagreb: Studio Hrg, 2003

Podaci o odgovornosti

Anđelinović, Deny ; Pavelić, Krešimir ; Kapitanović, Sanja ; Anđelinović, Šimun ; Tomić, Snježana ; Marasović, Dujomir ; Erceg Ivkošić, Ivana ; Kuret, Sendi ; Franulović, Vesna ; Primorac, Dragan

engleski

Expression of the nm23-H1 gene and loss of heterozygosity in malignant melanoma

Nm23-H1 is metastasis suppressor gene that encodes nucleoside diphosphate kinase (NDPK) which plays an important role in metastasis formation of human tumors. In order to investigate its role in the progression of the malignant melanoma we analyzed 51 primary malignant melanoma and eleven melanoma metastases according to the expression level of nm23-H1 and loss of heterozygosity. Nm23-H1 gene instability of 51 melanoma samples compared with normal tissue samples analysed by PCR loss of heterozygosity assay using specific oligonucleotide primers.Thirty three (64, 7%) informative samples were found, among them ten (30, 3%) showed LOH regardless of the Clark and Breslow stage of the malignant melanoma. Ten nm23-H1 protein immunoreactivity was positive in 45 (88, 2%)malignant melanoma samples but no statistically significant correlations between the nm23-H1 expression and Clark's and Breslow's stage were found. In this study eleven primary malignant melanoma showed metastasis. One patient was not informative (homozygous), five patients showed the same fragment length (noLOH) in primary and metastatic malignant cells with the same nm23-H1 expression. In two cases primary tumors turned from noLOH into LOH in metastatic tumors and this was followed by a decrease in the nm23-H1 expression. An association between tumor stage according to Clark and Breslow and nm23-H1 protein levels as well as LOH have not been found in malignant melanoma.

nm23-H1; malignant melanoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2003.

objavljeno

Podaci o matičnoj publikaciji

3rd European-American School in Forensic Genetics and Mayo Clinic Course in Advanced Molecular and Cellular Medicine, abstract book

Primorac, Dragan

Zagreb: Studio Hrg

Podaci o skupu

3rd European-American School in Forensic Genetics and Mayo Clinic Course in Advanced Molecular and Cellular Medicine

poster

01.09.2003-05.09.2003

Zagreb, Hrvatska

Povezanost rada

Kliničke medicinske znanosti